NVO and AMGN square off as GLP-1 leadership, pipeline depth, and diversification set up a compelling healthcare stock comparison.
The birthday girl opted for a curve-clinging white dress that clung to her slender figure, fishnet stockings, glittering ruby ...
The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...
NDTV Profit on MSN
Rupee's new lows, 100% FDI in insurance cos, and Ozempic's India launch — the week that was
From the rupee's continued slide, the Cabinet's approval of two reform bills, to Ozempic's launch in India, here are the key news events that shaped the week gone by.
Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Industry insiders are gearing up for weight-loss drugs to shake up the ...
Hosted on MSN
The Pen Cap That Flies Back
This video reveals a simple pen trick that looks like real magic. The performer rubs the pen cap on his shirt and blows on the pen to make it seem like the cap flies back on its own. The real secret ...
The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...
The Centers for Medicare and Medicaid Services announced that prices for 15 prescription drugs, including Ozempic, would be lowered under Medicare. NBC News' Marquise Francis reports on the ...
People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications. The company announced that through the end ...
For a limited time, patients can get a steep discount on the popular medications, as long as they’re paying out of pocket Steve Christo/Corbis/Corbis/Getty Ozempic ...
Novo Nordisk A/S is undercutting archrival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to compete on price as it tries to claw back a larger share of the U.S.
The maker of the blockbuster weight loss and diabetes drugs Wegovy and Ozempic have cut the prices for most versions of these medications. Novo Nordisk dropped the price for injectable Wegovy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results